Artivion Inc - Company Profile

Powered by

All the data and insights you need on Artivion Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Artivion Inc Strategy Report

  • Understand Artivion Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Artivion Inc: Overview

Select Item

Artivion Inc (Artivion), formerly CryoLife Inc, is a medical device company that manufactures and distributes biosurgical devices and implantable human tissues for cardiac and vascular surgical procedures for the treatment of aortic disease. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, bovine pericardium, and mitral chordal repair products, photofix products and Jotec products. The company products includes physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US and Hechinger, Germany. The company distributes its products through a network of the direct sales force in the UK, Austria, France, Germany, Ireland, and Switzerland, and independent distributors in the rest of Europe, the Middle East, and Africa. It commercializes products in more than 85 countries worldwide. Artivion is headquartered in Atlanta, Georgia, the US.

 Gain a 360-degree view of Artivion Inc and make more informed decisions for your business Gain a 360-degree view of Artivion Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 1655 Roberts Boulevard N W, Kennesaw, Georgia, 30144
Website artivion.com
Telephone 1 770 4193355
No of Employees 1,300
Industry Medical Equipment
Ticker Symbol & Exchange AORT (NYSE)
Revenue (2022) $313.8M 5% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -29.4% (2022 vs 2021)
Market Cap* $847.5M
Net Profit Margin (2022) XYZ -23.4% (2022 vs 2021)
* As of and is in US$
View Artivion Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Artivion Inc premium industry data and analytics

50+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Artivion Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Cardiac Allografts:
Aortic Valve Allograft
Pulmonary Human Cardiac Branch and Trunk Patch
XYZ
XYZ
XYZ
Understand Artivion Inc portfolio and identify potential areas for collaboration Understand Artivion Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Regulatory Approval In May, the company received premarket application approval from the US FDA for PERCLOT Absorbable Hemostatic System for use to control bleeding in certain open and laparoscopic surgical procedures.
2022 Corporate Changes/Expansions In January, the company changed its name from CryoLife, Inc. to Artivion, Inc.
2021 Asset Disposal In July, the company sold certain assets related to PerClot Polysaccharide Hemostatic System (PHS) to Baxter Healthcare for US$ 60.8 million.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Artivion Inc Pfizer Inc Abbott Laboratories Medtronic Plc Edwards Lifesciences Corp
Headquarters United States of America United States of America United States of America Ireland United States of America
City Kennesaw New York Abbott Park Dublin Irvine
State/Province Georgia New York Illinois - California
No. of Employees 1,300 83,000 115,000 95,000 17,300
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
J. Patrick Mackin President; Chief Executive Officer; Chairman Executive Board 2015 56
D. Ashley Lee Chief Financial Officer; Executive Vice President; Chief Operating Officer Senior Management 2004 58
Amy D. Horton, CPA Chief Accounting Officer; Vice President Senior Management 2006 52
Jean F. Holloway Corporate Secretary; General Counsel; Chief Compliance Officer; Senior Vice President Senior Management 2015 65
Matthew A. Getz Vice President; Chief Human Resources Officer Senior Management 2019 54
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Artivion Inc key executives to enhance your sales strategy Gain insight into Artivion Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward